Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Endometrial Cancer Stage I: later-stage trial registry

3 of 3 indexed Endometrial Cancer Stage I trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Endometrial Cancer Stage I: 3 US clinical trials tracked, 3 recruiting.

Endometrial Cancer Stage I is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Queensland Centre for Gynaecological Cancer, running 1 of these trials.

Enrollment posture brief

Registry condition endometrial-cancer-stage-i

OPEN 3 | RECR 100% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Endometrial Cancer Stage (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Endometrial Cancer Stage I

Endometrial Cancer Stage I lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Endometrial Cancer Stage I on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Endometrial Cancer Stage I is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Endometrial Cancer Stage I records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

TH BSO without retroperitoneal node dissection Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted Procedure
1 trials
TH BSO with SNB Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted Procedure
1 trials
Physical exam Other
1 trials
CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral Other
1 trials

US sites by state

Facility locations filed on Endometrial Cancer Stage I trials. A trial with sites in several states counts in each.

Texas 1 trials
Pennsylvania 1 trials
New York 1 trials
New Jersey 1 trials
Minnesota 1 trials
Massachusetts 1 trials
Florida 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Endometrial Cancer Stage I page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Endometrial Cancer Stage I condition card totals 3 registered trials; most-linked intervention TH BSO without retroperitoneal node dissection Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.